Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.

Bae KT, Zhou W, Shen C, Landsittel DP, Wu Z, Tao C, Chapman AB, Torres VE, Yu ASL, Mrug M, Bennett WM, Harris PC; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):823-833. doi: 10.2215/CJN.10360818. Epub 2019 May 14.

PMID:
31088850
2.

Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Yu ASL, Shen C, Landsittel DP, Grantham JJ, Cook LT, Torres VE, Chapman AB, Bae KT, Mrug M, Harris PC, Rahbari-Oskoui FF, Shi T, Bennett WM; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Kidney Int. 2019 May;95(5):1253-1261. doi: 10.1016/j.kint.2018.12.023. Epub 2019 Mar 4.

PMID:
30922668
3.

Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.

McKenzie KA, El Ters M, Torres VE, Harris PC, Chapman AB, Mrug M, Rahbari-Oskoui FF, Bae KT, Landsittel DP, Bennett WM, Yu ASL, Mahnken JD.

BMC Nephrol. 2018 Dec 27;19(1):378. doi: 10.1186/s12882-018-1182-0.

4.

AI and Clinicians: Not a Mutually Exclusive Zero-Sum Game.

Bae KT.

IEEE Pulse. 2018 Sep-Oct;9(5):20. doi: 10.1109/MPUL.2018.2866355.

PMID:
30273138
5.

Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease.

Dad T, Abebe KZ, Bae KT, Comer D, Torres VE, Czarnecki PG, Schrier RW, Steinman TI, Moore CG, Chapman AB, Kaya D, Tao C, Braun WE, Winklhofer FT, Brosnahan G, Hogan MC, Miskulin DC, Rahbari Oskoui F, Flessner MF, Perrone RD.

Kidney Int Rep. 2018 Jan 6;3(3):619-624. doi: 10.1016/j.ekir.2017.12.011. eCollection 2018 May.

6.

A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease.

Seliger SL, Abebe KZ, Hallows KR, Miskulin DC, Perrone RD, Watnick T, Bae KT.

Am J Nephrol. 2018;47(5):352-360. doi: 10.1159/000488807. Epub 2018 May 18.

7.

Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma.

Noda Y, Goshima S, Kawada H, Kawai N, Miyoshi T, Matsuo M, Bae KT.

AJR Am J Roentgenol. 2018 Jun;210(6):1252-1258. doi: 10.2214/AJR.17.18595. Epub 2018 Apr 9.

PMID:
29629801
8.

Genomic Analysis to Avoid Misdiagnosis of Adults With Bilateral Renal Cysts.

Gulati A, Bae KT, Somlo S, Watnick T.

Ann Intern Med. 2018 Jul 17;169(2):130-131. doi: 10.7326/L17-0644. Epub 2018 Mar 27. No abstract available.

PMID:
29582070
9.

A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features.

Furlan A, Almusa O, Yu RK, Sagreiya H, Borhani AA, Bae KT, Marsh JW.

Br J Radiol. 2018 Jun;91(1086):20170962. doi: 10.1259/bjr.20170962. Epub 2018 Apr 4.

10.

Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?

Brosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VE, The Halt Pkd Investigators.

Curr Hypertens Rev. 2018;14(1):39-47. doi: 10.2174/1573402114666180322110209.

11.

Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.

Brosnahan GM, Abebe KZ, Moore CG, Rahbari-Oskoui FF, Bae KT, Grantham JJ, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Miskulin DC, Steinman TI, Torres VE; HALT-PKD Trial Investigators.

Am J Kidney Dis. 2018 May;71(5):666-676. doi: 10.1053/j.ajkd.2017.10.023. Epub 2018 Jan 3.

12.

Is Magnetic Resonance Imaging Detection of Kidney Iron Deposition Increased in Haptoglobin 2-2 Genotype Carriers with Type 1 Diabetes?

Costacou T, Orchard TJ, Moon CH, Bae KT, Fried L, Evans RW.

Antioxid Redox Signal. 2018 Sep 10;29(8):735-741. doi: 10.1089/ars.2017.7444. Epub 2018 Feb 7.

13.

Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.

Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, Bennett WM, Chapman AB; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28.

14.

Simultaneous acquisition of MR angiography and diagnostic images of abdomen at view-sharing multiarterial phases and comparing the effect of two different contrast agents.

Noda Y, Goshima S, Namimoto T, Shinkawa N, Nakagawa M, Kajita K, Kawada H, Kawai N, Tanahashi Y, Matsuo M, Bae KT, Hirai T, Yamashita Y.

J Magn Reson Imaging. 2018 Jul;48(1):102-110. doi: 10.1002/jmri.25925. Epub 2017 Dec 16.

PMID:
29247585
15.

ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing.

Braun WE, Abebe KZ, Brosnahan G, Patterson CG, Chapman AB, Harris PC, Hogan MC, Perrone RD, Torres VE, Miskulin DC, Steinman TI, Winklhofer FT, Rahbari-Oskoui FF, Czarnecki PG, Bae KT, Grantham JJ, Flessner MF, Schrier RW.

Am J Kidney Dis. 2018 Feb;71(2):294-296. doi: 10.1053/j.ajkd.2017.09.008. Epub 2017 Dec 2. No abstract available.

16.

Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.

Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, Perrone RD, Steinman TI, Abebe KZ, Rahbari-Oskoui FF, Yu ASL, Harris PC, Bae KT, Hogan M, Miskulin D, Chonchol M.

J Am Soc Nephrol. 2018 Feb;29(2):571-578. doi: 10.1681/ASN.2017070819. Epub 2017 Nov 8.

17.

Importance of Better Human-Computer Interaction in the Era of Deep Learning: Mammography Computer-Aided Diagnosis as a Use Case.

Nishikawa RM, Bae KT.

J Am Coll Radiol. 2018 Jan;15(1 Pt A):49-52. doi: 10.1016/j.jacr.2017.08.027. Epub 2017 Oct 31. No abstract available.

PMID:
29097047
18.

Gadoxetic acid-enhanced high temporal-resolution hepatic arterial-phase imaging with view-sharing technique: Impact on the LI-RADS category.

Goshima S, Noda Y, Kajita K, Kawai N, Koyasu H, Kawada H, Matsuo M, Bae KT.

Eur J Radiol. 2017 Sep;94:167-173. doi: 10.1016/j.ejrad.2017.06.023. Epub 2017 Jul 3.

PMID:
28709718
19.

Computer-aided diagnosis program for classifying the risk of hepatocellular carcinoma on MR images following liver imaging reporting and data system (LI-RADS).

Kim Y, Furlan A, Borhani AA, Bae KT.

J Magn Reson Imaging. 2018 Mar;47(3):710-722. doi: 10.1002/jmri.25772. Epub 2017 May 26.

PMID:
28556283
20.

Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.

Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ; CRISP Investigators.

Kidney Int. 2017 Nov;92(5):1206-1216. doi: 10.1016/j.kint.2017.03.026. Epub 2017 May 20.

21.

Liver Surface Nodularity as a Biomarker for Detection and Evaluation of Cirrhosis.

Goshima S, Bae KT.

Radiology. 2017 Jun;283(3):921-922. doi: 10.1148/radiol.2017170112. No abstract available.

PMID:
28514213
22.

Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.

Brosnahan GM, Abebe KZ, Rahbari-Oskoui FF, Patterson CG, Bae KT, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Perrone RD, Steinman TI, Torres VE; HALT PKD Investigators.

Curr Hypertens Rev. 2017;13(2):109-120. doi: 10.2174/1573402113666170427142815.

23.

Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease.

Shen C, Landsittel D, Irazabal MV, Yu AS, Chapman AB, Mrug M, Grantham JJ, Bae KT, Bennett WM, Flessner MF, Torres VE; CRISP Investigators.

Am J Kidney Dis. 2017 Mar;69(3):482-484. doi: 10.1053/j.ajkd.2016.10.021. Epub 2016 Dec 24. No abstract available.

24.

Analysis of contrast time-enhancement curves to optimise CT pulmonary angiography.

Zhu J, Wang Z, Kim Y, Bae SK, Tao C, Gong J, Bae KT.

Clin Radiol. 2017 Apr;72(4):340.e9-340.e16. doi: 10.1016/j.crad.2016.11.018. Epub 2016 Dec 24.

PMID:
28027777
25.

Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.

Torres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, Braun WE, Steinman TI, Brosnahan G, Hogan MC, Rahbari FF, Grantham JJ, Bae KT, Moore CG, Flessner MF.

Kidney Int. 2017 Feb;91(2):493-500. doi: 10.1016/j.kint.2016.10.018. Epub 2016 Dec 16.

26.

Improved diagnosis of common bile duct stone with single-shot balanced turbo field-echo sequence in MRCP.

Noda Y, Goshima S, Kojima T, Kawaguchi S, Kawada H, Kawai N, Koyasu H, Matsuo M, Bae KT.

Abdom Radiol (NY). 2017 Apr;42(4):1183-1188. doi: 10.1007/s00261-016-0990-6.

PMID:
27891550
27.

Development of a 7 T RF coil system for breast imaging.

Kim J, Santini T, Bae KT, Krishnamurthy N, Zhao Y, Zhao T, Ibrahim TS.

NMR Biomed. 2017 Jan;30(1). doi: 10.1002/nbm.3664. Epub 2016 Nov 11.

28.

Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease.

Kim Y, Bae SK, Cheng T, Tao C, Ge Y, Chapman AB, Torres VE, Yu AS, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT.

Phys Med Biol. 2016 Nov 21;61(22):7864-7880. Epub 2016 Oct 25.

29.

Biliary tract enhancement in gadoxetic acid-enhanced MRI correlates with liver function biomarkers.

Noda Y, Goshima S, Kajita K, Kawada H, Kawai N, Koyasu H, Matsuo M, Bae KT.

Eur J Radiol. 2016 Nov;85(11):2001-2007. doi: 10.1016/j.ejrad.2016.09.003. Epub 2016 Sep 9.

PMID:
27776652
30.

Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.

Irazabal MV, Abebe KZ, Bae KT, Perrone RD, Chapman AB, Schrier RW, Yu AS, Braun WE, Steinman TI, Harris PC, Flessner MF, Torres VE; HALT Investigators.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1857-1865. doi: 10.1093/ndt/gfw294.

31.

Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.

Pejchinovski M, Siwy J, Metzger J, Dakna M, Mischak H, Klein J, Jankowski V, Bae KT, Chapman AB, Kistler AD.

Nephrol Dial Transplant. 2017 Mar 1;32(3):487-497. doi: 10.1093/ndt/gfw243.

PMID:
27382111
32.

Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients.

Casteleijn NF, Messchendorp AL, Bae KT, Higashihara E, Kappert P, Torres V, Meijer E, Leliveld AM.

Clin Exp Nephrol. 2017 Jun;21(3):375-382. doi: 10.1007/s10157-016-1297-1. Epub 2016 Jun 23.

33.

Experimental and numerical analysis of B1(+) field and SAR with a new transmit array design for 7T breast MRI.

Kim J, Krishnamurthy N, Santini T, Zhao Y, Zhao T, Bae KT, Ibrahim TS.

J Magn Reson. 2016 Aug;269:55-64. doi: 10.1016/j.jmr.2016.04.012. Epub 2016 Apr 23.

34.

Mapping blood flow directionality in the human brain.

Park SH, Do WJ, Choi SH, Zhao T, Bae KT.

Magn Reson Imaging. 2016 Jul;34(6):754-764. doi: 10.1016/j.mri.2016.03.005. Epub 2016 Mar 8.

PMID:
26968145
35.

Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.

Goshima S, Kanematsu M, Noda Y, Kawai N, Kawada H, Ono H, Bae KT.

AJR Am J Roentgenol. 2016 Mar;206(3):518-25. doi: 10.2214/AJR.15.15138.

PMID:
26901007
36.

Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.

Heyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, Bae KT, Schrier RW, Perrone RD, Braun WE, Steinman TI, Mrug M, Yu AS, Brosnahan G, Hopp K, Irazabal MV, Bennett WM, Flessner MF, Moore CG, Landsittel D, Harris PC; HALT PKD and CRISP Investigators.

J Am Soc Nephrol. 2016 Sep;27(9):2872-84. doi: 10.1681/ASN.2015050583. Epub 2016 Jan 28.

37.

Enhancement of functional MRI signal at high-susceptibility regions of brain using simultaneous multiecho multithin-slice summation imaging technique.

Kim T, Zhao T, Bae KT.

J Magn Reson Imaging. 2016 Aug;44(2):478-85. doi: 10.1002/jmri.25170. Epub 2016 Jan 28.

PMID:
26821385
38.

Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.

Kim Y, Ge Y, Tao C, Zhu J, Chapman AB, Torres VE, Yu AS, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):576-84. doi: 10.2215/CJN.08300815. Epub 2016 Jan 21.

39.

Inter-Slice Blood Flow and Magnetization Transfer Effects as A New Simultaneous Imaging Strategy.

Han PK, Barker JW, Kim KH, Choi SH, Bae KT, Park SH.

PLoS One. 2015 Oct 14;10(10):e0140560. doi: 10.1371/journal.pone.0140560. eCollection 2015.

40.

F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.

Noda Y, Goshima S, Kanematsu M, Watanabe H, Kawada H, Kawai N, Ono H, Bae KT.

Ann Nucl Med. 2016 Jan;30(1):11-7. doi: 10.1007/s12149-015-1023-1. Epub 2015 Sep 4.

PMID:
26337532
41.

Closeout of the HALT-PKD trials.

Moore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, Flessner MF, Bae KT, Abebe KZ, Hogan MC.

Contemp Clin Trials. 2015 Sep;44:48-55. doi: 10.1016/j.cct.2015.07.017. Epub 2015 Jul 29.

42.

Findings in pancreatic MRI associated with pancreatic fibrosis and HbA1c values.

Noda Y, Goshima S, Tanaka K, Osada S, Tomita H, Hara A, Horikawa Y, Takeda J, Kajita K, Watanabe H, Kawada H, Kawai N, Kanematsu M, Bae KT.

J Magn Reson Imaging. 2016 Mar;43(3):680-7. doi: 10.1002/jmri.25019. Epub 2015 Jul 22.

PMID:
26201823
43.

Diffusion kurtosis imaging of the pancreas for the assessment of HbA1c levels.

Noda Y, Kanematsu M, Goshima S, Horikawa Y, Takeda J, Kondo H, Watanabe H, Kawada H, Kawai N, Tanahashi Y, Bae KT.

J Magn Reson Imaging. 2016 Jan;43(1):159-65. doi: 10.1002/jmri.24982. Epub 2015 Jun 12.

PMID:
26074129
44.

Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma.

Goshima S, Kanematsu M, Noda Y, Kondo H, Watanabe H, Bae KT.

AJR Am J Roentgenol. 2015 May;204(5):W543-9. doi: 10.2214/AJR.14.13235.

PMID:
25905960
45.

18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.

Noda Y, Kanematsu M, Goshima S, Suzui N, Hirose Y, Matsunaga K, Nishibori H, Kondo H, Watanabe H, Kawada H, Kawai N, Tanahashi Y, Bae KT.

Eur Radiol. 2015 Oct;25(10):3009-16. doi: 10.1007/s00330-015-3687-2. Epub 2015 Apr 9.

PMID:
25854217
46.

A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.

Bhutani H, Smith V, Rahbari-Oskoui F, Mittal A, Grantham JJ, Torres VE, Mrug M, Bae KT, Wu Z, Ge Y, Landslittel D, Gibbs P, O'Neill WC, Chapman AB; CRISP Investigators.

Kidney Int. 2015 Jul;88(1):146-51. doi: 10.1038/ki.2015.71. Epub 2015 Apr 1.

47.

Whole-body CT with high heat-capacity X-ray tube and automated tube current modulation--effect of tube current limitation on contrast enhancement, image quality and radiation dose.

Kanematsu M, Kondo H, Miyoshi T, Goshima S, Noda Y, Tanahashi Y, Bae KT.

Eur J Radiol. 2015 May;84(5):877-83. doi: 10.1016/j.ejrad.2015.01.019. Epub 2015 Feb 16.

PMID:
25740700
48.

MRI of the thyroid for differential diagnosis of benign thyroid nodules and papillary carcinomas.

Noda Y, Kanematsu M, Goshima S, Kondo H, Watanabe H, Kawada H, Bae KT.

AJR Am J Roentgenol. 2015 Mar;204(3):W332-5. doi: 10.2214/AJR.14.13344.

PMID:
25714319
49.

Investigation of inter-slice magnetization transfer effects as a new method for MTR imaging of the human brain.

Barker JW, Han PK, Choi SH, Bae KT, Park SH.

PLoS One. 2015 Feb 9;10(2):e0117101. doi: 10.1371/journal.pone.0117101. eCollection 2015.

50.

Computer-aided assessment of hepatic contour abnormalities as an imaging biomarker for the prediction of hepatocellular carcinoma development in patients with chronic hepatitis C.

Goshima S, Kanematsu M, Kondo H, Watanabe H, Noda Y, Fujita H, Bae KT.

Eur J Radiol. 2015 May;84(5):811-5. doi: 10.1016/j.ejrad.2015.01.009. Epub 2015 Jan 22.

PMID:
25650331

Supplemental Content

Support Center